This product is intended for adults only
Potential benefits people commonly report include: However, research involving TB-500 remains limited, especially in human clinical trials
Frequently Asked Questions Research References Novel recombinant fusion protein analogues of insulin-like growth factor (IGF)-I indicate the relative importance of IGF-binding protein and receptor binding for enhanced biological potency (J Mol Endocrinol, 1992) Effects of interactions between IGFBPs and IGFs on the plasma clearance and in vivo biological activities of IGFs and IGF analogs (Growth Regul, 1993) Effects of insulin and LongR3 on serum-free Chinese hamster ovary cell cultures expressing two recombinant proteins (Biotechnol Prog, 2000) IGF-1 LR3 1mg 37.99
- Ph hp vi tt c ln da, nam v n u c th s dng
The FDA approved the Wegovy pill (oral semaglutide 25 mg, once daily) in late 2025, and it launched in the US in early January 2026
Important Notice This product is intended exclusively for laboratory and scientific research purposes